Atrioventricular junctional ablation: The good, the bad, the better

BACKGROUND: The management of patients with atrial fibrillation and an abnormally fast ventricular response has been through the use of pharmacologic agents. In those cases where rate control cannot be achieved pharmacologically, a standard approach has been atrioventricular (AV) junctional ablation...

Descripción completa

Detalles Bibliográficos
Autores principales: Scherlag, Benjamin J., Elkholey, Khaled, Stavrakis, Stavros, Jackman, Warren M., Po, Sunny S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Topics in Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183872/
https://www.ncbi.nlm.nih.gov/pubmed/34113885
http://dx.doi.org/10.1016/j.hroo.2020.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183872/
https://www.ncbi.nlm.nih.gov/pubmed/34113885
http://dx.doi.org/10.1016/j.hroo.2020.06.003

Ejemplares similares